“Improvements in Lesional Pain and Itch Symptoms With Brodalumab in Psoriasis Studies”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s17, https://doi.org/10.25251/skin.1.supp.16.